CS logo
small CS logo
Asklepios Klinik Lich

Lich, Germany
Hospital in Lich, Hessen
Goethestraße 4, 35423 Lich

About Asklepios Klinik Lich


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials
AGO Research GmbH
1
ETOP IBCSG Partners Foundation
1
Medical Research Council
1
Menarini Group
1
Total Rows: 4

Clinical Trials at Asklepios Klinik Lich


During the past decade, Asklepios Klinik Lich conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients
2006-12-01
2011-06-01
Terminated
888
Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Newly Diagnosed Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cavity Cancer
2006-04-01
Completed
1,520
Letrozole in Preventing Cancer in Postmenopausal Women Who Have Received 4-6 Years of Hormone Therapy for Hormone Receptor-Positive, Lymph Node-Positive, Early-Stage Breast Cancer
2007-08-01
2019-05-15
Completed
4,884
Evaluation of Optimal Treatment With Bevacizumab in Patients With Platinum-sensitive Recurrent Ovarian Cancer
2013-05-01
2021-01-01
Completed
682

Rows per page:

1–4 of 4

Clinical Trials Sponsors and Collaborators


In terms of collaborators to trials, out of the total clinical trials conducted in "Asklepios Klinik Lich" #1 collaborator was "ARCAGY/ GINECO GROUP" with 1 trials as a collaborator, "Arbeitsgemeinschaft Gynaekologische Onkologie Austria" with 1 trials as a collaborator, "Australia New Zealand Gynaecological Oncology Group" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "Scottish Gynaecological Cancer Study Group" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.
Created with Highcharts 11.1.0Top Leading SponsorsAGO Research GmbH: 1AGO Research GmbH: 1ETOP IBCSG PartnersFoundation: 1ETOP IBCSG PartnersFoundation: 1Medical Research Council: 1Medical Research Council: 1Menarini Group: 1Menarini Group: 1

Created with Highcharts 11.1.0Top CollaboratorsARCAGY/ GINECO GROUP: 1ARCAGY/ GINECO GROUP: 1ArbeitsgemeinschaftGynaekologischeOnkologie Austria: 1ArbeitsgemeinschaftGynaekologischeOnkologie Austria: 1Australia New ZealandGynaecologicalOncology Group: 1Australia New ZealandGynaecologicalOncology Group: 1Breast International Group: 1Breast International Group: 1Scottish GynaecologicalCancer Study Group: 1Scottish GynaecologicalCancer Study Group: 1

Clinical Trials Conditions at Asklepios Klinik Lich


According to Clinical.Site data, the most researched conditions in "Asklepios Klinik Lich" are "Ovarian Cancer" (2 trials), "Breast Cancer" (1 trials), "Fallopian Tube Cancer" (1 trials), "Primary Peritoneal Cavity Cancer" (1 trials) and "Recurrent Platinum-sensitive Ovarian Cancer" (1 trials). Many other conditions were trialed in "Asklepios Klinik Lich" in a lesser frequency.

Clinical Trials Intervention Types at Asklepios Klinik Lich


Most popular intervention types in "Asklepios Klinik Lich" are "Biological" (3 trials), "Drug" (3 trials), "Other" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Abagovomab" (1 trials), "Bevacizumab" (1 trials), "Carboplatin" (1 trials), "Letrozole" (1 trials) and "PLD" (1 trials). Other intervention names were less common.

Clinical Trials Genders at Asklepios Klinik Lich


The vast majority of trials in "Asklepios Klinik Lich" are 4 trials for "Female" genders.

Clinical Trials Status at Asklepios Klinik Lich


Currently, there are NaN active trials in "Asklepios Klinik Lich". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Asklepios Klinik Lich, undefined suspended trials, and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Asklepios Klinik Lich, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By PhasePhase 3: 4Phase 3: 4Phase 2: 1Phase 2: 1

Created with Highcharts 11.1.0Trials StatusCompleted: 3Completed: 3Terminated: 1Terminated: 1

Departments of Asklepios Klinik Lich


Asklepios Klinik Lich has several departments that took part in Clinical trials: "Asklepios-Fachkliniken Muenchen-Gauting; Onkologie" - 8 trials, "Neurologische Klinik Bad Salzhausen" - 4 trials, "Asklepios Klinik Nord - Ochsenzoll" - 3 trials, "Asklepios Kllinikum Bad Abbach; Klinik für Rheumatologie und Klinische Immunologie" - 3 trials, "Asklepios Orthopadische Klinik Lindenlohe" - 3 trials, "Asklepios Neurologische Klinik Falkenstein" - 2 trials, "Asklepios Klinik St. Augustin GmbH, Kinder- und Jugendmedizin, Kinder-Hämatologie und Onkologie" - 2 trials, "Asklepios Klinik Hamburg Altona, II. Med. Klinik" - 2 trials, "Asklepios Klinik St. Georg - Chirurgisch-Traumatologisches Zentrum" - 2 trials